Liver Cancer

Oncology Solutions

Liver cancer is the fifth most common cancer, accounting for 8.2 percent of all cancer deaths worldwide.1 The incidence is rising across all continents including in the United States. A study published in JAMA Oncology, December 2017 found the incidence of liver cancer increased by 75 percent worldwide between 1990 and 2015.2 Effective surveillance programs with imaging could offer early diagnosis and provide an opportunity for better treatment options.

The Patient Journey

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • Computed Tomography

    Your need for quality patient care at low dose with greater productivity and affordability is more important than ever.  That’s why we design CT syst...

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

The latest in Oncology


INSIGHTS THE PULSE
1. IARC database of 2018.
2. JAMA Oncol. 2017;3(12):1683-1691. doi:10.1001/jamaoncol.2017.3055Published online October 5, 2017. Corrected on December 14, 2017.

JB04823XX

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606